Predictive value of aortic propagation velocity for cardiovascular events in asymptomatic individuals with elevated
Leila Bigdelu1, Mostafa Ahmadi2, Bahram Shahri3
1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences , Mashhad , Iran.
Insights
Aortic propagation velocity (APV) may help predict cardiovascular disease (CVD) events in high-risk patients. Lower APV levels were associated with an increased risk of major adverse cardiovascular events (MACE) over one year.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Vascular Physiology
Background:
- Cardiovascular disease (CVD) prediction remains a significant clinical challenge.
- Aortic propagation velocity (APV), an echocardiographic index, shows potential for CVD risk assessment.
- Limited research exists on APV's prognostic value in high-risk populations.
Purpose of the Study:
- To investigate the association between APV and the incidence of major adverse cardiovascular events (MACE) in patients with an elevated ASCVD score.
- To determine a potential cut-off value for APV in predicting MACE.
- To evaluate APV as an adjunctive prognostic marker for CVD risk.
Main Methods:
- Prospective cohort study involving 60 patients with ASCVD score > 10.
- Echocardiography was performed to measure APV, categorizing patients into normal (>56 cm/s) and abnormal (≤56 cm/s) groups.
- Follow-up for 1 year to record MACE (non-fatal MI, stroke, revascularization, or cardiovascular death).
- Logistic regression and ROC curve analysis were employed for statistical evaluation.
Main Results:
- Seven patients developed MACE within the 1-year follow-up period.
- A significantly higher rate of MACE was observed in the abnormal APV group (6 cases) compared to the normal APV group (1 case) (p=0.039).
- Logistic regression indicated a significant relationship between decreased APV and MACE development (OR=2.10 per 10 cm/s decrease).
- ROC analysis suggested a cut-off APV of 49.75 cm/s for MACE prediction (AUC=0.710).
Conclusions:
- APV demonstrates a trend towards prognostic value for MACE in high-risk individuals.
- Abnormal APV may serve as a potential adjunctive marker for cardiovascular risk stratification.
- Larger prospective studies are warranted to confirm these findings and establish APV's role in clinical practice.
Abstract:
Prediction of cardiovascular diseases (CVD) is a challenge that cardiologists have always faced all the times. Aortic propagation velocity (APV) is an echocardiography index that can be helpful with this regard; however, few studies have addressed the condition. This prospective cohort study was conducted at the outpatient clinic of Imam Reza and Quaem Hospital in Mashhad, Iran. It was conducted on cases with ASCVD score of > 10. All the cases underwent echocardiography and APV was measured for them. The cases were classified into two groups including normal APV (> 56 cm/s) and abnormal APV (≤ 56 cm/s). They were followed for a duration of 1 year and the rate of CVD was compared between the two groups. Moreover, ROC curve analysis was used for determining a cut-off. The primary endpoint was a composite of major adverse cardiovascular events (MACE): non-fatal MI, non-fatal stroke, coronary revascularization, or cardiovascular death. A total of 60 cases, including 37 (61.7%) males and 23 (38.3%) females, were enrolled. After 1 year of follow-up, 7 cases developed MACE: 6 in the abnormal APV group and 1 in the normal APV group (p = 0.039). Logistic regression analysis showed a significant relationship between APV and MACE development (OR = 2.10 per 10 cm/s decrease in APV; 95% CI 1.116-3.932; p = 0.02). ROC curve analysis proposed a cut-off of 49.75 cm/s with a sensitivity of 85.7% and specificity of 60% (AUC = 0.710; 95% CI 0.585-0.835; p = 0.072). Seven cases developed MACE (non-fatal MI, stroke, revascularization, or CV death). APV showed a trend toward prognostic value for MACE, suggesting it may serve as a potential adjunctive marker in this high-risk population; however, larger studies are needed to confirm these findings.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(two-step method)
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

